NCT03016091 2025-02-18A Trial of Pembrolizumab for Refractory Atypical and Anaplastic MeningiomaRabin Medical CenterPhase 2 Terminated18 enrolled 9 charts
NCT00464620 2018-11-23Trial of Dasatinib in Advanced SarcomasSarcoma Alliance for Research through CollaborationPhase 2 Completed366 enrolled 16 charts